The haematopoietic stem cell niche: a new player in cardiovascular disease?
Annas Al-Sharea, Man Kit Sam Lee, Louise E Purton, Edwin D Hawkins, Andrew J Murphy
Cardiovasc Res | Published : 2019
Haematopoiesis, the process of blood production, can be altered during the initiation or progression of many diseases. Cardiovascular disease (CVD) has been shown to be heavily influenced by changes to the haematopoietic system, including the types and abundance of immune cells produced. It is now well established that innate immune cells are increased in people with CVD, and the mechanisms contributing to this can be vastly different depending on the risk factors or comorbidities present. Many of these changes begin at the level of the haematopoietic stem and progenitor cells (HSPCs) that reside in the bone marrow (BM). In general, the HSPCs and downstream myeloid progenitors are expanded v..View full abstract